Skip to main content
Shandong Weigao Orthopaedic Device Co.,Ltd. logo

Shandong Weigao Orthopaedic Device Co.,Ltd. — Investor Relations & Filings

Ticker · 688161 ISIN · CNE1000050W9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 483 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688161

About Shandong Weigao Orthopaedic Device Co.,Ltd.

http://www.wegortho.com/

Shandong Weigao Orthopaedic Device Co., Ltd. specializes in the research, development, production, and sale of orthopedic medical devices. The company offers a comprehensive product portfolio categorized into spine, trauma, joint, and sports medicine segments. Key products include spinal fixation systems, intramedullary nails, bone plates, hip and knee prostheses, and arthroscopic repair materials. The organization focuses on providing integrated clinical solutions through advanced manufacturing processes and rigorous quality control systems. Its research and development initiatives aim to innovate surgical techniques and improve patient outcomes. The company serves a global network of hospitals and medical institutions, maintaining a significant presence in the orthopedic implant market through its diverse range of high-performance medical consumables and specialized surgical instrumentation.

Recent filings

Filing Released Lang Actions
北京市中伦（深圳）律师事务所关于山东威高骨科材料股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 76% confidence The document is a legal opinion letter (“法律意见书”) provided by an external law firm (Zhong Lun) regarding the legality of convening and conducting Shandong Weigao’s 2025 Annual General Meeting (AGM). It is not the actual AGM materials (presentations or minutes), nor a company-published report (e.g., Annual Report, interim report), financial data release, or proxy solicitation; instead it is a compliance/legal document opining on the AGM process. Such third-party legal opinions filed for regulatory compliance fall under the catch-all category of Regulatory Filings (RNS).
2026-05-28 Chinese
山东威高骨科材料股份有限公司2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is an announcement of the 2025 Annual General Meeting resolutions of Shandong Weigao Orthopedic Materials Co., detailing attendance, voting results for each proposal, and legal witness statements. It provides share counts, percentages, and passes/fails of shareholder votes. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-28 Chinese
山东威高骨科材料股份有限公司2025年年度股东会会议资料
AGM Information Classification · 95% confidence The document is clearly the complete set of materials (agenda, proposals, reports, attachments) prepared for the company’s 2025 Annual General Meeting, including board work reports, profit distribution proposals, session rules, etc. It is not an announcement of a report publication or a standalone financial report, but rather the actual meeting materials for shareholders. Therefore, it should be classified as AGM Information (AGM-R).
2026-05-20 Chinese
山东威高骨科材料股份有限公司关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 80% confidence The document is an announcement of the company’s participation in an online investor reception event. It contains no financial statements or substantive data, nor is it an AGM presentation, earnings release, or regulatory certification. It is a corporate announcement required by regulators, falling into the general “Regulatory Filings” category (RNS).
2026-05-12 Chinese
关于签订募集资金专户存储三方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the signing of a tripartite supervision agreement for the storage of raised funds in a special account. It details the amount of funds raised, the opening of a special account, the parties involved in the agreement, and the terms of supervision and management of the funds. There are no financial statements or detailed financial performance data included. The document is primarily about the management and regulatory compliance of fundraising proceeds, not a financial report or audit. The length is 2380 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Capital/Financing Update (CAP), as it relates to fundraising activities and the management of raised capital.
2026-05-06 Chinese
山东威高骨科材料股份有限公司2026年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "山东威高骨科材料股份有限公司2026年第一季度报告" which translates to "Shandong Weigao Orthopedic Materials Co., Ltd. 2026 First Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management commentary for the first quarter of 2026. The report explicitly states it is a quarterly report and includes unaudited financial statements for the quarter ending March 31, 2026. The length of the document (over 14,000 characters) and the presence of substantive financial data confirm it is a full interim/quarterly financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.